IntrinsicIntrinsic

Other Events ·

On June 17, 2026, stockholders approved an amendment and restatement of the 2022 Omnibus Incentive Plan, increasing…

ICUSeaStar Medical Holding Corp

On June 17, 2026, stockholders approved an amendment and restatement of the 2022 Omnibus Incentive Plan, increasing the number of authorized shares of common stock from 207,046 to 896,546. The company also elected John Neuman as a Class I director and ratified WithumSmith+Brown, PC as its independent registered public accounting firm for the fiscal year ending December 31, 2026. SeaStar Medical Holding Corporation operates in the medical technology industry and develops medical devices.

More from SeaStar Medical Holding Corp

Explore ICU